Potential Solutions to Resistant Infections, Including MRSA
Potential Solutions to Resistant Infections, Including MRSA

Show: Health Talk Radio w/ Melanie Cole M.S.

Warning: getimagesize(http://www.healthradio.net/images/stories/web_pics/sharebar.gif) [function.getimagesize]: failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden in /home/servers/healthradio.net/www.healthradio.net/modules/mod_valaddthis_15/helper.php on line 113
Nicholas Landekic
Science and Medicine: Infections
Topic Info
Nicholas Landekic, President and CEO of PolyMedix joins the show to discuss a new antimicrobial polimer that can burst the bubble on antibiotic resistant bacteria.
Guest Info
Nicholas Landekic, has served as President, Chief Executive Officer and Director and a Founder of PolyMedix, Inc. since inception in 2002. Mr. Landekic has more than 20 years of pharmaceutical experience. From 2000 to 2002, he was President and Chief Executive Officer of Locus Discovery, during which time the company raised $83 million in financings, built one of the most powerful supercomputer clusters in the world according to TFCC, and received the accolade “One of the 10 hottest biotech start-ups” from Drug Discovery Magazine. From 1995 to 2000, Mr. Landekic was Senior Vice President of Corporate Development & Investor Relations at Guilford Pharmaceuticals. From 1991 to 1995, Mr. Landekic served as Senior Director of Business Development at Cephalon and, from 1988 to 1991, served as Senior Manager for Strategic Marketing at Bristol-Myers Squibb. He also held positions in Finance and Business Development at Johnson & Johnson Corporation (McNeil Pharmaceutical) from 1985 to 1988 and positions in the research laboratories at the Mt. Sinai Medical Center from 1982 to 1983. Mr. Landekic received an M.B.A. from the State University of New York at Albany, an M.A. in Biology from Indiana University and a B.S. in Biology from Marist College.
Melanie Cole, M.S.
Rate this listing
0 vote



More On-Demand Shows: